Junping Pei

发表

Emerging strategies to overcome resistance to third-generation EGFR inhibitors

L. Ouyang, Guan Wang, Jifa Zhang, 2022, Journal of Hematology & Oncology.

A sulfhydryl blocking reagent BT-4 sensitizes cisplatin-based micelle prodrugs for efficient treatment of breast cancer.

M. Gou, L. Ouyang, Yang Zhou, 2022, International journal of pharmaceutics.

Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy

L. Ouyang, Guan Wang, Aoxue Wang, 2022, Acta pharmaceutica Sinica. B.

Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease

L. Ouyang, Guan Wang, Bo Liu, 2021, Acta pharmaceutica Sinica. B.

The roles of computer-aided drug synthesis in drug development

L. Ouyang, Guan Wang, Yumeng Zhu, 2021, Green Synthesis and Catalysis.

Targeting Lysosomal Degradation Pathways: New Strategies and Techniques for Drug Discovery.

L. Ouyang, Guan Wang, Qiu Sun, 2021, Journal of medicinal chemistry.

Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases.

L. Ouyang, Guan Wang, Aoxue Wang, 2022, Journal of medicinal chemistry.

Small Molecules Targeting Activated Cdc42-Associated Kinase 1 (ACK1/TNK2) for the Treatment of Cancers.

L. Ouyang, Guan Wang, F. Lin, 2021, Journal of medicinal chemistry.

Design, Synthesis, and Antitumor Activity of Potent and Selective EGFR L858R/T790M Inhibitors and Identification of a Combination Therapy to Overcome Acquired Resistance in Models of Non-small-cell Lung Cancer.

L. Ouyang, Guan Wang, Aoxue Wang, 2023, Journal of medicinal chemistry.

Developing potent LC3-targeting AUTAC tools for protein degradation with selective autophagy.

L. Ouyang, Guan Wang, Aoxue Wang, 2021, Chemical communications.